(1S,4R)-Methyl 4-aminocyclopent-2-enecarboxylate (2R,3R)-2,3-dihydroxysuccinate is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of complex organic molecules. Its unique stereochemistry and functional groups make it valuable for constructing chiral compounds, particularly in the development of antiviral and anticancer drugs. The compound's cyclopentene ring and carboxylate group allow for versatile chemical modifications, enabling the creation of targeted therapeutic agents. Additionally, it is employed in research settings to study enzyme inhibition and receptor binding, contributing to the discovery of new drug candidates. Its role in asymmetric synthesis also highlights its importance in producing enantiomerically pure substances, which are critical for effective and safe medications.